Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust
|
|
- Easter Short
- 6 years ago
- Views:
Transcription
1 Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Authors: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Dr Tasneem Pirani, ST4 in Gastroenterology Dr Henna Wong, CT1 Core Medical Training Wing Lam Yeung, Medical Directorate Pharmacist Lead Director: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Version No: 6 Implementation May 2010 Date: Ratified By: Drugs and Therapeutics Committee, April 2010 Date of Next May 2011 Review:
2 1 Introduction The Government recommended daily limits for alcohol are 2-3 units for a woman and 3-4 units for a man. Alcohol misuse can manifest as physical or psychological symptoms across a whole range of specialties. It is important for all healthcare professionals to be aware of patients that are at risk of withdrawal so that appropriate investigations and treatment can be instituted. We need to avoid either under- or over- treatment which may lead to delirium tremens (DT) or over treatment, which is associated with sedation and respiratory compromise. Benzodiazepines, especially Chlordiazepoxide, are central to the management of alcohol withdrawal. Chlordiazepoxide is used due to its reduced street appeal and dependence potential compared to Diazepam or Chlormethiazole. Purpose of Guidelines These guidelines should be used from initial admission through to discharge as an aid to ascertain who is at risk and how to prevent complications of alcohol withdrawal. 1. Identify patients at risk Ask about alcohol intake per day and type of alcohol Has there been a previous attendance related to alcohol? CAGE questionnaire o Cut down o Annoyed o Guilty o Eye-opener Figure 1: Table to estimate number of units of alcohol per type of beverage PINT CAN GLASS SINGLE BOTTLE BEER/LAGER/CIDER ml 1.3 STRONG BEER/LAGER/CIDER WINE SHERRY/PORT/MARTINI 1 SPIRITS (GIN/VODKA/WHISKY) * 750ml * 1 30 ALCOPOPS * see website (depends on strength/size) 275ml 1.4
3 2 2. Alcohol Withdrawal Syndrome (AWS) Figure 2: Symptoms of withdrawal states Uncomplicated withdrawal (Symptoms typically seen within 6-8 hours of last drink, peaking at hours) Tremors Sweating Fever Nausea, vomiting Anxiety Irritability Tachycardia Insomnia Anorexia Auditory/visual hallucinations Delirium tremens (onset commonly within 2-3 days of cessation) Auditory/visual hallucinations Severe tremor Confusion, disorientation, agitation Temp > 38.3 Autonomic over activity Delusions Alcohol withdrawal seizures (within hours, rare beyond 48 hours) Usually grand-mal 3. Treatment of AWS See flow diagram on page 4 Patients prescribed Chlordiazepoxide should be monitored for respiratory depression. Monitor pulse, oximetry and respiratory rate. Review patient after TWO doses of Chlordiazepoxide. 4. Adjunctive treatment Patients are at risk of Wernicke s and subsequent progression to Korsakoff s psychosis due to thiamine depletion. All patients should be assessed for ophthalmoplegia/nystagmus/confusion/ataxia (difficult if patients acutely intoxicated) All patients who misuse alcohol and present with alcohol withdrawal should be prescribed the following: o Pabrinex 2 pairs tds for 3 days o Once parenteral vitamin supplementation has finished, commence: Thiamine 200mg od for at least 1 month Vitamin B co-strong II once a day for at least 1 month
4 3 5. Treatment of alcohol withdrawal seizures These usually occur within hours of alcohol cessation If status epilepticus occurs, this should be treated with Lorazepam or Diazepam as Phenytoin is not effective. IV Diazepam 10mg stat, at a maximum rate of 5mg per min and repeated once after 10 minutes (if necessary) OR alternatively IV Lorazepam 4mg stat, at a maximum rate of 2mg per min and repeated once after 10minutes (if necessary) Inform ITU 6. Alternatives to Chlordiazepoxide Lorazepam can be used sublingually 30mg Chlordiazepoxide 1 mg Lorazepam Consider oral Lorazepam in patients with severe liver impairment or established cirrhosis as it is shorter-acting and therefore avoids the excessive build up of metabolites and over-sedation. Discuss with the Gastroenterology Team as soon as possible. 7. Checklist prior to discharge Check LFTs, Clotting, FBC [ ] Provide details of drug /alcohol addiction unit i.e. Self referral to ACORN [ ] o ACORN phone numbers Frimley Guildford Patients should NOT be discharged on Chlordiazepoxide except on Consultant advice Discussion with Gastroenterology Team prior to arranging follow up [ ] References A Time to Act: Improving Health and Outcomes in Liver Disease British Association of the study of the liver October 2009 O Shea et al. Alcoholic liver disease. American Association of the study of the liver. Practice Guidelines Hepatology 2010
5 4 MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME All patients need the following investigations: U & E s, Mg2+, PO4-, Ca2+, Folate/B12, LFT s, FBC, Clotting Screen, Blood glucose. Watch for hyponatraemia. Vitamin supplementation for all patients prescribed with reducing regime of Chlordiazepoxide PABRINEX 2 pairs TDS IV for 3 days Once parenteral supplementation complete, start oral vitamins for at least 1 month THIAMINE 200mg od VITAMIN B CO-STRONG II od Does this patient drink >8-10 units of alcohol per day AND/OR have any alcohol withdrawal signs/symptoms? Anxiety/agitation/irritability Sweating Fever Tremor Tachycardia Nausea/vomiting/retching Insomnia Hallucinations Mild systolic hypertension Anorexia YES Give vitamin supplementation (see yellow box) NO No treatment necessary, continue to monitor Classification of symptoms Use the following Chlordiazepoxide regime Mild Moderate SEVERE <100 units /week units /week >200 units/week Time Day Day Day Day Day mg 10mg 5mg 5mg mg 10mg 5mg mg 10mg 5mg mg 20mg 10mg 10mg 5mg Time Day Day Day Day Day Day mg 20mg 10mg 5mg 5mg mg 20mg 10mg 5mg mg 20mg 10mg 5mg mg 30mg 20mg 10mg 10mg 5mg Plus PRN 5mg Chlordiazepoxide Plus PRN 5-10mg Chlordiazepoxide Maximum total daily dose of 300mg Time Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day mg 30mg 20mg 10mg 10mg 5mg 5mg mg 30mg 20mg 10mg 5mg 5mg mg 30mg 20mg 10mg 5mg 5mg mg 30mg 20mg 10mg 10mg 5mg 5mg Plus prn 10mg Chlordiazepoxide Maximum total daily dose of Chlordiazepoxide 300mg SEVERE ALCOHOL WITHDRAWAL Initiate high dose vitamin therapy & Chlordiazepoxide Monitor blood glucose 2hrly - correct hypoglycaemia (ALWAYS give Pabrinex first as may precipitate Wernicke s encephalopathy) If NBM or swallowing problems: IV Diazepam (Diazemuls) 10mg, repeated if necessary after not less than 4 hours (max 5mg/min by slow IV injection), or PR diazepam (rectal tubes) 500 micrograms/kg (maximum 30mg), repeated after 12 hours if required. Avoid IM where possible erratic absorption and bleeding risk Treat convulsions (page 3) and discuss with ITU
Alcohol Detoxification (Inpatient) Prescribing Guidelines
Alcohol Detoxification (Inpatient) Prescribing Guidelines Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the procedure, including date) This
More informationALCOHOL WITHDRAWAL GUIDELINES
ALCOHOL WITHDRAWAL GUIDELINES Policy author Accountable Executive Lead Approving body Policy reference Dr M Lewis, Gastroenterologist; Professor J A Vale, Clinical Toxicologist; Dr D A Robertson, Alcohol
More informationLead for Gastroenterology Lee Dodge Alcohol Liaison 03/03/2015. Clive Gibson Safeguarding Adults Lead Nurse 03/03/2015
Acute Alcohol Withdrawal Management for Adult Inpatients Type: Clinical Guideline Register No: 1409 Status: Public on ratification Developed in response to: Best Practice Contributes to CQC Outcome number:
More informationPharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01. Planned review: December 2017
Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V01 V01 issued: Issue 1- Dec 14 Issue 2 April 17 Planned review: December 2017 PPT-PGN
More informationUniversity Hospitals of Leicester NHS Trust
University Hospitals of Leicester NHS Trust ACUTE ALCOHOL WITHDRAWAL MANAGEMENT Guidelines for Management of Acute Medical Emergencies Approved By: Policy and Guideline Committee Date Approved: 21 November
More informationAcute Alcohol Withdrawal Protocol
Acute Alcohol Withdrawal Protocol Controlled document This document is uncontrolled when downloaded or printed Reference number Version 1 Author WHHT: C268 Dr Mohamed Shariff Date ratified August 2014
More informationAlcohol withdrawal. Clinical features
Alcohol withdrawal Clinical features Severity increase with amount consumed; uncommon with < drinks per day. Predictable pattern: patients with previous withdrawal seizures are at high risk for recurrence.
More informationAlcohol withdrawal including the Symptom triggered CIWA score Management
Alcohol withdrawal including the Symptom triggered CIWA score Management Classification: Policy Lead Author: Ruth Brown Alcohol specialist Nurse Additional author(s): Hailey Pennington Authors Division:
More informationPharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02. Planned review: Dec 2020
Pharmacological Therapy Policy Practice Guidance Note Management of Acute Alcohol Withdrawal in Adults (Over 18) - V02 Issue No: Issue 1- Dec 17 Planned review: Dec 2020 PPT-PGN 22 Part of NTW(C)38 Pharmacological
More informationAlcohol Withdrawal Guidelines
SH CP 197 Alcohol Withdrawal Guidelines Summary: Keywords: Target Audience: Identification, assessment and management of alcohol dependence and harmful alcohol use in people presenting for assessment or
More informationTitle Alcohol Withdrawal Management Guidelines
Document Control Title Alcohol Withdrawal Management Guidelines Author Directorate Date Version Issued 0.1 Dec 2009 0.2 Mar 2010 0.3 Nov 2010 Status Draft 0.4 Sep 2015 1.0 Jan 2016 2.0 Nov Final 2018 Main
More informationComplicated Withdrawal
Complicated Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts
More informationWithdrawal.
Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General
More informationPrescribing for substance misuse: alcohol detoxification. Clinical background
Prescribing for substance misuse: alcohol detoxification POMH-UK Quality Improvement Programme. Topic 14a: baseline Clinical background 1 2014 The Royal College of Psychiatrists. For further information
More informationEducation Pack for the Alcohol Liaison Nurse Service
Education Pack for the Alcohol Liaison Nurse Service Welcome to the Alcohol Liaison Nurse Service, this pack is designed to help you get the most out of your time here with us today and set some objectives
More informationSubstance Misuse Nurse service Belfast Trust
Substance Misuse Nurse service Belfast Trust Alcohol is the most widely available socially acceptable drug in Northern Ireland It can be an addictive substance It is a depressant- slows down the central
More informationAlcohol Issues in the Acute General Hospital Setting
Alcohol Issues in the Acute General Hospital Setting (Guidelines and Management) This procedural document supersedes: PAT/T 25 version 3 - Guidelines for the Management of Alcohol Issues in the Acute General
More informationComplicated Withdrawal
Complicated Withdrawal Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@Swedish.org Disclosures: Shamim Nejad,
More informationMethodist Hospital Alcohol Withdrawal Suggested Guidelines
Methodist Hospital Alcohol Withdrawal Suggested Guidelines S. Prizada Sattar, MD Teri L Gabel, Pharm.D.,BCPP Sidney Kauzlarich, MD Subhash Bhatia, MD Mitzi Bollinger, RN S. Prizada Sattar, MD 6-20-3 Rationale
More informationTreatment of Alcohol and Opiate Withdrawal
Objectives Treatment of Alcohol and Opiate Withdrawal Renee Striker, Pharm.D., BCPS, BCPP Pharmacy Clinical Specialist Huron Hospital East Cleveland, Ohio Outline the diagnostic criteria for substance
More informationAssessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance
CONCISE GUIDANCE Clinical Medicine 01, Vol 1, No : 71 Assessment Main title and management of alcohol dependence and withdrawal in the acute hospital: concise guidance Author head name Stephen Stewart
More informationROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS
ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS Dr. Anita Rao? ASK SCREEN Refer HELP T T Ranganathan Clinical Research Foundation TTK Hospital IV Main Road, Indira
More informationCurrent Clinical Patterns in the Management of Alcohol Withdrawal Syndrome (AWS)
1 Current Clinical Patterns in the Management of Alcohol Withdrawal Syndrome (AWS) The goal of the survey is to evaluate current practices for the inpatient management of AWS in adult hospitals located
More informationManaging presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead
Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead PLAN OF PRESENTATION Assessment of alcohol dependence Psychiatric
More informationA Guide to Alcoholism and Problem Drinking
A Guide to Alcoholism and Problem Drinking Alcoholism is a word which many people use to mean alcohol dependence (alcohol addiction). Some people are problem drinkers without being dependent on alcohol.
More informationConsulted With: Post/Committee/Group: Date: John Crome Drug and Alcohol Liaison Emergency Care
THE MANAGEMENT OF OPIOID WITHDRAWAL IN ADULT PATIENTS Type: Clinical Guideline Register No: 18007 Status: Public on ratification Developed in response to: Contributes to CQC Outcome number: 12 Best practice
More informationManagement of Alcohol Dependence
STANDARD TREATMENT GUIDELINES Management of Alcohol Dependence Quick Reference Guide February 2016 Ministry of Health & Family Welfare Government of India 1 Table of Contents Objectives-... 3 Diagnosis...
More informationComplicated Withdrawal
Complicated Withdrawal Shamim Nejad, MD Medical Director, Division of Psychosocial Oncology Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@Swedish.org Disclosures: Shamim
More informationAlcohol Issues in the Acute General Hospital Setting
Alcohol Issues in the Acute General Hospital Setting (Guidelines and Management) This procedural document supersedes: PAT/T 25 version 2 - Guidelines for the Management of Alcohol Issues in the Acute General
More informationAlcoholism And Addiction In The Elderly
Alcoholism And Addiction In The Elderly 1) The National Institute on Drug Abuse states that addiction is defined as a chronic, relapsing disease. a) Brain b) Moral c) Physical d) Impulse Control 2) Approximately
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationNHS Fife Guidance for the Identification, Assessment and Management of Harmful Drinking and Alcohol Dependence
NHS Fife Guidance for the Identification, Assessment and Management of Harmful Drinking and Alcohol Dependence Staff working in services provided and funded by the NHS who care for people who potentially
More informationSedative Hypnotics. Isopropyl Alcohol H H H H OH H. H H Ethyl Alcohol (Ethanol)
Sedative Hypnotics Alcohol - The most commonly used Sedative- Hypnotic. Probably the oldest psychoactive drug used by humans. Alcohol use is common our society. 2/3 of people drink. 10% are problem drinkers
More informationINPATIENT ALCOHOL WITHDRAWAL PRESCRIBING GUIDELINES MAY 2018
INPATIENT ALCOHOL WITHDRAWAL PRESCRIBING GUIDELINES MAY 2018 Policy title Inpatient alcohol withdrawal Prescribing Guidelines Policy PHA28B reference Policy category Clinical Relevant to Trust-wide any
More informationCIWA-AR CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE
CIWA-AR CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE SAM G CAMPBELL MB BCH, FCFP(EM), DIP PEC(SA), FCCHL, FRCP(EDIN) PROFESSOR OF EMERGENCY MEDICINE DALHOUSIE UNIVERSITY, HALIFAX, NOVA SCOTIA.
More informationNorthern Ireland Alcohol Use Disorders Care Pathway. management in the acute hospital setting
Northern Ireland Alcohol Use Disorders Care Pathway management in the acute hospital setting Main Content 1. Introduction 2 2. Alcohol Withdrawal Syndrome 3 2.1. Delirium tremens 3 2.2. Seizures 4 2.3.
More informationALCOHOL RELATED BRAIN DAMAGE (ARBD)
FACT SHEET 01 ALCOHOL RELATED BRAIN DAMAGE (ARBD) This fact sheet will help you get a better understanding of Alcohol Related Brain Damage, how it can present, what causes it and how someone with ARBD
More informationIn our patients the cause of seizures can be broadly divided into structural and systemic causes.
Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SUBSTANCE DEPENDENCY For full details of the of the medication discussed in this formulary including side effects,
More informationSedation Hold/Interruption and Weaning Protocol ( Wake-up and Breathe )
PROTOCOL Sedation Hold/Interruption and Weaning Protocol ( Wake-up and Breathe ) Page 1 of 6 Scope: Population: Outcome: Critical care clinicians and providers. All ICU patients intubated or mechanically
More informationPlease review the following slides prior to class. Information from these slides will be used to answer patient cases. Come prepared!
Please review the following slides prior to class Information from these slides will be used to answer patient cases. Come prepared! Alcohol and Opiate Dependence Reference Slides Substances of Abuse A
More information1/10/2017. A common Alcoholics Anonymous (AA) saying is There is no problem that alcohol cannot make worse.
Alcohol still addicts more people than all other drugs combined Understand difference between alcohol use, abuse and dependence Learn the potential physiological and emotional affects of alcohol Distinguish
More informationMEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets
MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Read this Medication Guide carefully before you start using WELLBUTRIN and each time you get a refill. There may be new information.
More informationDRAFT FOR CONSULTATION
1) What is the accuracy of a tool and/or clinical judgement for the a) assessment b) monitoring of patients at risk of acute alcohol withdrawal? 2) Does the assessment and monitoring of patients with acute
More informationSedative-Hypnotics. Sedative Agents (General Considerations)
Sedative Agents (General Considerations) No best sedative agent Any agent given in sufficient dosage can produce any level of sedation Intravenous dosing is more predictable then intramuscular or oral
More informationProvider Update: Alcohol Withdrawal Order Set Edits
Provider Update: Alcohol Withdrawal Order Set Edits Situation: A revised Alcohol Withdrawal Order Set and new CIWA-Ar scoring tool will go LIVE February 12, 2018. Background: The latest guidelines for
More informationNorthern Ireland Alcohol Use Disorders Care Pathway. management in the acute hospital setting
Northern Ireland Alcohol Use Disorders Care Pathway management in the acute hospital setting Main Content 1. Introduction 2 2. Alcohol Withdrawal Syndrome 3 2.1. Delirium tremens 3 2.2. Seizures 4 2.3.
More informationTalk outline. Some definitions. Emergency epilepsy now what? Recognising seizure types. Dr Richard Perry. Management of status epilepticus
Emergency epilepsy now what? Dr Richard Perry Imperial College NHS Trust Imperial College Talk outline Recognising seizure types Management of status epilepticus Some definitions Epileptic seizure A clinical
More informationNCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease
NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant
More informationPrescribing for substance misuse: alcohol detoxification
Prescribing for substance misuse: alcohol POMH-UK Quality Improvement Programme. Topic 14b (re-audit) Prepared by the Prescribing Observatory for Mental Health-UK for Non-participating Trusts Published
More informationSCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead
SCENARIOS IN SUBSTANCE MISUSE By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead ALCOHOL SCENARIOS DON T PRESCRIBE LIBRIUM AS YOU ARE CONTRIBUTING TO A SECOND ADDICTION WITHOUT TREATING THE
More informationSECTION 10: MANAGEMENT OF ALCOHOL, OPIOID AND BENZODIAZEPINE DEPENDENCE. Formulary and Prescribing Guidelines
SECTION 10: MANAGEMENT OF ALCOHOL, OPIOID AND BENZODIAZEPINE DEPENDENCE Formulary and Prescribing Guidelines 10.1 Introduction This document covers the safe prescribing and management for service users
More informationALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS
ALCOHOL ASSESSMENT AND DETOXIFICATION POLICY FOR INPATIENTS Version: 4 Date issued: August 2017 Review date: August 2020 Applies to: All staff working within Trust Inpatient settings This document is available
More informationMultiple Choice Questions
Multiple Choice Questions 25yo M presents without psychiatric or medical history, with complaint of tremor to the ER. He denies drinking alcohol but his friend at bedside takes you to the side and reports
More informationManagement of Severe Agitation
Management of Severe Agitation Key Points 1. The management of the severely agitated or violent patient embraces psychological, physical and pharmacological approaches. 2. Psychological methods focus on
More informationCritical Care Pharmacological Management of Delirium
Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care
More informationGeneral Effects. Special Patient Populations. Alcoholism. Who is an Alcoholic
Alcohol Use & Abuse in Acutely and Critically Ill Patients: Don t Be Fooled General Effects Christine Schulman, RN, MS, CNS, CCRN Clinical Nurse Specialist & Consultant Trauma & Critical Care Nursing Portland,
More informationAlcoholism. Social environment, stress, mental health, family history, age, ethnic group, and gender all influence the risk for the condition.
SAY NO TO ALCOHOL Alcoholism Alcoholism is a chronic and often progressive disease that includes problems controlling your drinking, being preoccupied with alcohol, continuing to use alcohol even when
More informationBrief guide: substance misuse services detoxification or withdrawal from drugs or alcohol
. Brief guide: substance misuse services detoxification or withdrawal from drugs or alcohol Context Detoxification or withdrawal is a key stage in achieving abstinence for people who are dependent on drugs
More informationBenzodiazepines. Benzodiazepines
: History 1950s - Invented by Swiss chemists who identified its sedative effects 1950s 60s - Chlordiazepoxide (Librium) marketed as a safer alternative to barbiturates; along with newer benzodiazepines
More informationLorazepam Tablets, USP
Lorazepam Tablets, USP DESCRIPTION: Lorazepam, an antianxiety agent, has the chemical formula, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H -1,4-benzodiazepin-2-one: Cl H N N O Cl OH It is a white
More informationDrugs in American Society CHD 601. Legal Drugs Alcohol
Drugs in American Society CHD 601 Legal Drugs Alcohol Unit 2 Last updated April 12, 2017 Edward Pierce, LCSW Overview From the last class Counseling videos Quiz 1 Process Other items Alcohol Biochemical
More informationBasics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR
Basics of Benzodiazepine Use Disorder DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members
More informationMedication Guide Clonazepam Tablets USP (kloe-na-za-pam)
Medication Guide Clonazepam Tablets USP (kloe-na-za-pam) Read this Medication Guide before you start taking clonazepam tablets and each time you get a refill. There may be new information. This information
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationAdministration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification. Standard Operating Procedure
Administration of High Dose Intra- Muscular Vitamin Supplements for Patients Undergoing Alcohol Detoxification Standard Operating Procedure DOCUMENT CONTROL: Version: 3 Ratified by: Quality Assurance Sub
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationBasics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR
Basics of Benzodiazepine Use Disorder DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members
More informationBrief tips on Using the Drink-less package for brief intervention for alcohol use disorders. The University of Sydney 2004
Brief tips on Using the Drink-less package for brief intervention for alcohol use disorders The University of Sydney 2004 What is the Drink-less package? Based on World Health Organization validated techniques
More informationVersion Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:
PATIENT GROUP DIRECTION (PGD) FOR THE INPATIENT ADMINISTRATION OF ORAL LORAZEPAM TO WORKING AGE AND OLDER PEOPLE (includes persons in a Place of Safety suite) Version Number: 5 Patient Group Direction
More informationOverview of Psychoactive Drug use
Overview of Psychoactive Drug use By Dr. Oladosu Ahmed Kayode Specialist in mental health Attending physician Dept. of psychiatry, GH Ilorin & Hopeville Psychiatric Hospital, Ilorin. Learning objectives
More informationCommunity alcohol detoxification in primary care
Community alcohol detoxification in primary care 1. Purpose The purpose of this primary care enhanced service is to improve the health and quality of life of people whose health may be compromised by their
More informationWhat else do I need to know about antidepressant medicines?
MEDICATION GUIDE Bupropion (bue-proe-pee-on) Hydrochloride Extended-Release Tablets (SR), 200 mg Read this Medication Guide carefully before you start taking bupropion hydrochloride extended-release tablets
More informationGUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD
GUIDELINES FOR ALCOHOL DETOXIFICATION AT HMP BEDFORD Policy Details NHFT document reference MMG027/HMP Version 1 Date Ratified May 2017 Ratified by HMP Bedford Drugs and Therapeutics Committee Implementation
More informationAdmit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)
https://providers.amerigroup.com Substance Use Disorder Withdrawal Management Prior Authorization and Continued Care Request (Use for American Society of Addiction Medicine [ASAM] withdrawal management
More informationAddictions in General Practice 16 th November 2017
Addictions in General Practice 16 th November 2017 Dr Anshul Swami in Addictions Consultant Psychiatrist Priory Hospital North London, Southgate Consultant telephone: 020 8920 5616 Consultant email: SueGranger@priorygroup.com
More informationMEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets
Page 25 the 75- or 100-mg tablets. The 100-mg tablet must be administered 4 times daily with at least 4 hours between successive doses, in order not to exceed the limit of 150 mg in a single dose. WELLBUTRIN
More informationA. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.
Pharmacology - Problem Drill 17: Central Nervous System Depressants Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully (2) Work the problems on paper as 1. occur(s)
More informationC AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS
C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage
More informationVandetanib. ICD-10 codes Codes with a pre-fix C73.
Vandetanib Indication First line treatment of histologically confirmed, unresectable, locally advanced or metastatic medullary thyroid cancer in patients with progressive and symptomatic disease. ICD-10
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationSession 2: Alcohol and Recovery 2-1
Session 2: Alcohol and Recovery 2-1 Alcohol in the Brain Alcohol upsets a delicate balance between chemical systems that stimulate and chemical systems that inhibit functions of the brain and body. Matrix
More informationBasics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR
Basics of Benzodiazepine Use Disorder DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker disclosure: One time lecture sponsored by Indivior about overlap of pain and opioid
More informationPABRINEX PRESCRIBING PROTOCOL JULY This policy supersedes all previous policies for medically assisted community alcohol withdrawal
PABRINEX PRESCRIBING PROTOCOL JULY 2015 This policy supersedes all previous policies for medically assisted community alcohol withdrawal Policy title Policy PHA55 reference Policy category Clinical Relevant
More informationHigh Risk Medications. University of Illinois at Chicago College of Nursing
High Risk Medications University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this module, participants will be better able to: 1. Define Gain high risk medications
More informationMethamphetamine Abuse During Pregnancy
Methamphetamine Abuse During Pregnancy Robert Davis, MD / r.w.davismd@gmail.com ❶ Statistics ❷ Pregnancy Concerns ❸ Postpartum Concerns ❹ Basic Science ❺ Best Practice Guidelines ❻ Withdrawal ❼ Recovery
More informationManaging presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead
Managing presenting problems with benzodiazepines By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead OUTLINE OF PRESENTATION Why Benzodiazepines (BDZ s) are used Mechanism of Action
More information1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER
1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER 1.1 GENERAL PRINCIPLES There are many causes of agitation in palliative care patients, which makes recommendations for treatment difficult.
More informationBenzodiazepines and Hypnotics
Benzodiazepines and Hypnotics Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version goes out of date):
More informationAlcohol abuse and dependence: diagnosis and treatment
Alcohol abuse and dependence: diagnosis and treatment Psychiatry lecture for medical students Erika Szily Semmelweis University 2016 Burden of excessive alcohol use Risk factor for Social problems, Financial
More informationPrescribing Framework for Naltrexone in Alcohol Relapse Prevention
Prescribing Framework for Naltrexone in Alcohol Relapse Prevention Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP s Name:... Communication We agree to treat this patient
More informationDate: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: Direct Line: f.adamsonanhs.
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date: 22nd March 2018 Our Ref: FANitaminMGPG/Mar18 Enquiries to Frances Adamson Extension: 56689 Direct Line: 01224 556689
More informationAlcohol Withdrawal: Assessment and Symptom-Triggered Treatment
Alcohol Withdrawal: Assessment and Symptom-Triggered Treatment 2016 Alcohol, or ethanol, is produced by the fermentation of yeast, sugars and starches. Yeast breaks sugar down into ethanol and carbon dioxide.
More informationPACKAGE LEAFLET: Information for the patient. DIAZEPAM Tablets 5 mg Solution for injection 10 mg / 2 ml (Diazepam)
PACKAGE LEAFLET: Information for the patient DIAZEPAM Tablets 5 mg Solution for injection 10 mg / 2 ml (Diazepam) Read this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationPATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY Version Number: 5 Patient Group Direction drawn up by: Name Ray Lyon Dr Al Amaladoss
More informationGuidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting
ANTICOAGULANT SERVICE Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting Introduction Fast loading of warfarin carries a risk of over anticoagulation
More informationMEDICATION GUIDE BuPROPion Hydrochloride Extended-Release Tablets, USP (SR) (byoo-proe-pee-on)
MEDICATION GUIDE BuPROPion Hydrochloride Extended-Release Tablets, USP (SR) (byoo-proe-pee-on) Read this Medication Guide carefully before you start taking Bupropion Hydrochloride Extended-Release Tablets,
More informationSpecialized terms used in this workbook and their meanings:
Glossary Specialized terms used in this workbook and their meanings: Absorption: The way alcohol enters the bloodstream. Alcohol is absorbed into the blood through the stomach and small intestine. Addiction:
More informationCLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY
This applies to adult patients only CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Yes Patient already taking phenytoin?
More informationWhat is the most important information I should know about midazolam?
midazolam (oral) Pronunciation: mye DAZ oh lam Brand: Versed What is the most important information I should know about midazolam? Midazolam can slow or stop your breathing, especially if you have recently
More information